Richard Jenner
@reggenomics.bsky.social
Professor of Molecular Biology
Head of Department of Cancer Biology and Pathology
University College London
Head of Department of Cancer Biology and Pathology
University College London
Reposted by Richard Jenner
We are recuiting two new Associate Professors here in Oxford Biochemistry. Come join us! Reach out to me if you have any questions. Please repost! tinyurl.com/mr3m7bd3
October 17, 2025 at 2:56 PM
We are recuiting two new Associate Professors here in Oxford Biochemistry. Come join us! Reach out to me if you have any questions. Please repost! tinyurl.com/mr3m7bd3
Interested in applying your molecular biology skills to improve tumour #immunotherapy?
@cruk-cityoflondon.bsky.social #PhD studentship available in my lab @ucl.ac.uk in collaboration with @diunguyenvnuk.bsky.social @qmbci.bsky.social
For more information and to apply: colcc.ac.uk/phd-students...
@cruk-cityoflondon.bsky.social #PhD studentship available in my lab @ucl.ac.uk in collaboration with @diunguyenvnuk.bsky.social @qmbci.bsky.social
For more information and to apply: colcc.ac.uk/phd-students...
October 10, 2025 at 10:29 AM
Interested in applying your molecular biology skills to improve tumour #immunotherapy?
@cruk-cityoflondon.bsky.social #PhD studentship available in my lab @ucl.ac.uk in collaboration with @diunguyenvnuk.bsky.social @qmbci.bsky.social
For more information and to apply: colcc.ac.uk/phd-students...
@cruk-cityoflondon.bsky.social #PhD studentship available in my lab @ucl.ac.uk in collaboration with @diunguyenvnuk.bsky.social @qmbci.bsky.social
For more information and to apply: colcc.ac.uk/phd-students...
Pleased to share our preprint describing a central role for #post-transcriptional processes in the response to cancer #immunotherapy. Huge amount of work led by Maria Vila de Mucha and @juliahlond.bsky.social with Sergio Quezada and @martint-babraham.bsky.social 1/8
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
A post-transcriptional regulatory checkpoint controls the response of tumor-infiltrating cytotoxic CD4+ T cells to immunotherapy
Acquisition of cytotoxic activity in CD4+ T cells (TCTX) can promote potent anti-tumor activity thus holding promise as a therapeutic approach. However, how this activity is regulated remains poorly u...
www.biorxiv.org
September 12, 2025 at 3:43 PM
Pleased to share our preprint describing a central role for #post-transcriptional processes in the response to cancer #immunotherapy. Huge amount of work led by Maria Vila de Mucha and @juliahlond.bsky.social with Sergio Quezada and @martint-babraham.bsky.social 1/8
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...